
Noble E. Jarrell
Examiner (ID: 19030)
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1625, 1699, 1609, 1624, 1622, 1629 |
| Total Applications | 1452 |
| Issued Applications | 961 |
| Pending Applications | 170 |
| Abandoned Applications | 340 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16460732
[patent_doc_number] => 10844066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => 2-amino-N-[7-methoxy-2, 3-dihydroimidazo-[1,2-c] quinazolin-5-yl] pyrimidine-5-carboxamides
[patent_app_type] => utility
[patent_app_number] => 16/082712
[patent_app_country] => US
[patent_app_date] => 2017-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15057
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16082712
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/082712 | 2-amino-N-[7-methoxy-2, 3-dihydroimidazo-[1,2-c] quinazolin-5-yl] pyrimidine-5-carboxamides | Feb 28, 2017 | Issued |
Array
(
[id] => 11662633
[patent_doc_number] => 20170151340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-01
[patent_title] => 'Conjugates Containing Hydrophilic Spacer Linkers'
[patent_app_type] => utility
[patent_app_number] => 15/431157
[patent_app_country] => US
[patent_app_date] => 2017-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 38372
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15431157
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/431157 | Conjugates containing hydrophilic spacer linkers | Feb 12, 2017 | Issued |
Array
(
[id] => 14482793
[patent_doc_number] => 10328157
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
[patent_app_type] => utility
[patent_app_number] => 15/423695
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 22546
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1836
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15423695
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/423695 | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule | Feb 2, 2017 | Issued |
Array
(
[id] => 16791638
[patent_doc_number] => 20210121455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-29
[patent_title] => OPIOID RECEPTOR ANTAGONIST CONJUGATE AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/074268
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13275
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074268 | Opioid receptor antagonist conjugate and use thereof | Jan 25, 2017 | Issued |
Array
(
[id] => 12490455
[patent_doc_number] => 09994765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Color conversion films with plasmon enhanced fluorescent dyes
[patent_app_type] => utility
[patent_app_number] => 15/415886
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 33
[patent_no_of_words] => 18820
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/415886 | Color conversion films with plasmon enhanced fluorescent dyes | Jan 25, 2017 | Issued |
Array
(
[id] => 12490455
[patent_doc_number] => 09994765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Color conversion films with plasmon enhanced fluorescent dyes
[patent_app_type] => utility
[patent_app_number] => 15/415886
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 33
[patent_no_of_words] => 18820
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/415886 | Color conversion films with plasmon enhanced fluorescent dyes | Jan 25, 2017 | Issued |
Array
(
[id] => 12490455
[patent_doc_number] => 09994765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Color conversion films with plasmon enhanced fluorescent dyes
[patent_app_type] => utility
[patent_app_number] => 15/415886
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 33
[patent_no_of_words] => 18820
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/415886 | Color conversion films with plasmon enhanced fluorescent dyes | Jan 25, 2017 | Issued |
Array
(
[id] => 12490455
[patent_doc_number] => 09994765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-12
[patent_title] => Color conversion films with plasmon enhanced fluorescent dyes
[patent_app_type] => utility
[patent_app_number] => 15/415886
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 33
[patent_no_of_words] => 18820
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 290
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415886
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/415886 | Color conversion films with plasmon enhanced fluorescent dyes | Jan 25, 2017 | Issued |
Array
(
[id] => 14761953
[patent_doc_number] => 10392361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-27
[patent_title] => Process for the synthesis of intermediates of Nebivolol
[patent_app_type] => utility
[patent_app_number] => 16/071741
[patent_app_country] => US
[patent_app_date] => 2017-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4062
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071741 | Process for the synthesis of intermediates of Nebivolol | Jan 22, 2017 | Issued |
Array
(
[id] => 13826507
[patent_doc_number] => 20190016738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => SUPRAMOLECULAR ASSEMBLY OF RIGID MACROCYCLES THROUGH COOPERATIVE HYDROGEN BOND INTERACTIONS
[patent_app_type] => utility
[patent_app_number] => 16/069940
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069940
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069940 | Supramolecular assembly of rigid macrocycles through cooperative hydrogen bond interactions | Jan 12, 2017 | Issued |
Array
(
[id] => 16460728
[patent_doc_number] => 10844062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Pyridine derivative inhibiting RAF kinase and vascular endothelial growth factor receptor, method for preparing same, pharmaceutical composition containing same, and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/074950
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 24145
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16074950
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/074950 | Pyridine derivative inhibiting RAF kinase and vascular endothelial growth factor receptor, method for preparing same, pharmaceutical composition containing same, and use thereof | Jan 10, 2017 | Issued |
Array
(
[id] => 11604042
[patent_doc_number] => 20170121344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/401767
[patent_app_country] => US
[patent_app_date] => 2017-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52920
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15401767
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/401767 | THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS | Jan 8, 2017 | Abandoned |
Array
(
[id] => 17221753
[patent_doc_number] => 11174243
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Succinate forms and compositions of Bruton's tyrosine kinase inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/319506
[patent_app_country] => US
[patent_app_date] => 2017-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 16338
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16319506
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/319506 | Succinate forms and compositions of Bruton's tyrosine kinase inhibitors | Jan 5, 2017 | Issued |
Array
(
[id] => 11588436
[patent_doc_number] => 20170112846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-27
[patent_title] => 'OXYGEN LINKED PYRIMIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 15/398851
[patent_app_country] => US
[patent_app_date] => 2017-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32165
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15398851
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/398851 | Oxygen linked pyrimidine derivatives | Jan 4, 2017 | Issued |
Array
(
[id] => 12448305
[patent_doc_number] => 09981953
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-05-29
[patent_title] => Contrast agent precursor and method for preparing the same
[patent_app_type] => utility
[patent_app_number] => 15/397998
[patent_app_country] => US
[patent_app_date] => 2017-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3546
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15397998
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/397998 | Contrast agent precursor and method for preparing the same | Jan 3, 2017 | Issued |
Array
(
[id] => 16492323
[patent_doc_number] => 10858347
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-08
[patent_title] => Multicyclic compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/066558
[patent_app_country] => US
[patent_app_date] => 2016-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29446
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066558
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/066558 | Multicyclic compounds and uses thereof | Dec 28, 2016 | Issued |
Array
(
[id] => 16680966
[patent_doc_number] => 10940425
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Compounds for the detection, capture and/or separation of polluting gases
[patent_app_type] => utility
[patent_app_number] => 16/064797
[patent_app_country] => US
[patent_app_date] => 2016-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 6148
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 283
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064797
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064797 | Compounds for the detection, capture and/or separation of polluting gases | Dec 22, 2016 | Issued |
Array
(
[id] => 13777777
[patent_doc_number] => 20190002427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => STEREOISOMER OF FLOCOUMAFEN, COMPOSITION AND RODENTICIDE BAIT COMPRISING SAME, AND METHOD FOR CONTROLLING TARGET RODENT PESTS
[patent_app_type] => utility
[patent_app_number] => 16/060864
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8208
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060864
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060864 | STEREOISOMER OF FLOCOUMAFEN, COMPOSITION AND RODENTICIDE BAIT COMPRISING SAME, AND METHOD FOR CONTROLLING TARGET RODENT PESTS | Dec 5, 2016 | Abandoned |
Array
(
[id] => 13478905
[patent_doc_number] => 20180290995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-11
[patent_title] => Process For Preparing Aminotetrahydropyrans
[patent_app_type] => utility
[patent_app_number] => 15/570781
[patent_app_country] => US
[patent_app_date] => 2016-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570781
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570781 | Process for preparing aminotetrahydropyrans | Nov 28, 2016 | Issued |
Array
(
[id] => 13139721
[patent_doc_number] => 10087181
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Compound as WNT signaling inhibitor, composition, and use thereof
[patent_app_type] => utility
[patent_app_number] => 15/359900
[patent_app_country] => US
[patent_app_date] => 2016-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11544
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15359900
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/359900 | Compound as WNT signaling inhibitor, composition, and use thereof | Nov 22, 2016 | Issued |